Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Rectal Neoplasms 11Glioblastoma 10Breast Neoplasms 10Lung Neoplasms 9Head and Neck Neoplasms 8Neoplasms 6Neoplasm Metastasis 6Brain Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Prostatic Neoplasms 5Leukemia 4Gliosarcoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Melanoma 3Leukemia, Myeloid, Acute 3Carcinoma, Squamous Cell 3Carcinoma, Renal Cell 3Carcinoma, Merkel Cell 3Adenocarcinoma Of Esophagus 3Xerostomia 2Waldenstrom Macroglobulinemia 2Small Cell Lung Carcinoma 2Recurrence 2Myelodysplastic Syndromes 2Mycosis Fungoides 2

Interventions

Cisplatin 3Pemetrexed 2Etoposide 2pomalidomide 1etoposide phosphate 1enzalutamide 1bemiparin 1apalutamide 1alvocidib 1abiraterone 1Radiation 1RRx-001 1Gemcitabine 1GSK2879552 1Depsipeptides 1Carboplatin 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Small Cell × Radiation × Clear all
NCT00447421 2009-10-28

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Eli Lilly and Company

Phase 1/2 Terminated
9 enrolled 6 charts
Thoracic

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡